Primary Biliary Cholangitis: Real World Outcomes in Context  

Nov 15 2024
Convention Center: Ballroom 20 BC
12:30 PM - 2:00 PM

World Class Speakers

Kris V Kowdley, MD, FACP, FACG, AGAF, FAASLD
Industry Presenter

Kris V Kowdley, MD, FACP, FACG, AGAF, FAASLD

Liver Institute Northwest
David EJ Jones, MD, PhD
Industry Presenter

David EJ Jones, MD, PhD

Newcastle University, UK
Alejandra Maria Villamil, MD
Industry Presenter

Alejandra Maria Villamil, MD

Description

This activity seeks to empower clinicians to effectively manage your patients with primary biliary cholangitis (PBC) and improve their outcomes. By enhancing your competence in monitoring disease activity and progression, identifying when there is a need for second-line therapy, and individualizing treatment for your patients, you will be better able to address delays in initiating appropriate therapy. Additionally, by providing real-world evidence on clinical outcomes beyond biomarkers and liver enzymes, such as decompensation, transplantation, and mortality, you will be better equipped to make more informed decisions about second-line therapy options.  

Supported by: An independent educational grant from Intercept 

Orgainzer: Medscape Education

For more information and to register, visit: https://events.medscapelive.org/website/79985/

Objectives

  • Have greater competence related to monitoring PBC disease activity and progression in practice
  • Have greater competence related to recognizing patients with PBC who require second-line therapy
  • Have greater competence related to selecting evidence-based second-line therapies for patients with PBC
  • Demonstrate greater confidence in their ability to tailor treatments for patients with PBC